Navigation Links
Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/4/2010

as compared to a net loss of $31.0 million or $0.33 per share in the third quarter of 2009.

Conference Call to Discuss Third Quarter 2010 Financial ResultsA conference call to review the financial results will be held today, Thursday, November 4, 2010 at 2 PM Pacific Time.  

Details are below:

The press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through Friday, November 19, 2010. To access the conference call, follow these instructions:Dial: (800) 798-2864 (U.S.); (617) 614-6206 (international)Passcode: 87996589 (Nektar is the host)An audio replay will also be available shortly following the call through Friday, November 19, 2010 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) with a passcode of 55049373.

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, or explained on the conference call, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About NektarNektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for Nektar's oral NKTR-118 development program to treat opioid-induced constipation and its NKTR-119 development program for the treatment of pain without constipation side effects. The company has additional pain compounds in prec
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
2. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
3. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
6. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... WOONSOCKET, R.I. , Aug. 27, 2014  CVS ... has entered into a new clinical affiliation with MedStar ... in Maryland and the ... access to high-quality, affordable health care services for patients. ... to have access to clinical support, medication counseling, chronic ...
(Date:8/27/2014)... , Aug. 27, 2014 Amgen (NASDAQ: ... Drug Administration (FDA) has granted priority review designation for ... Ivabradine is an oral drug that inhibits the ... sinoatrial node, the body,s cardiac pacemaker. 1 Ivabradine ... on myocardial contractility or ventricular repolarization. 1 Heart ...
(Date:8/27/2014)... Aug. 27, 2014  UBM Medica US announces that ... community for medical imaging professionals, presents special reporting about ... Imaging Management,s 2014 Annual Meeting . ... , 11 Principles of Successful Labor Management ... greater profitability. , Why Don,t Patients Know ...
Breaking Medicine Technology:CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3
... 12 American Life League,s historic Personhood ... in adult stem cell research and regenerative ... Deisher, founder and CEO of AVM Biotechnology ... is speaking on over 17 years of ...
... YORK, Jan. 12 The Michael J. Fox Foundation ... two clinical studies that will test drugs already approved ... disease. Because both drugs being tested are already known ... move swiftly toward regulatory approval for use in Parkinson,s ...
Cached Medicine Technology:Stem Cell Pioneer to Speak to A.L.L. Personhood Conference 2Michael J. Fox Foundation Awards $2.9 Million for Two New Parkinson's Disease Clinical Trials 2
(Date:8/27/2014)... National Resident Matching Program International ... Medical Education in Europe (AMEE) Conference being held at ... – September 3, 2014. As an exhibitor, NRMPI ... community, share the benefits of its matching services, and ... in countries throughout the world. , “Exhibiting ...
(Date:8/27/2014)... 28, 2014 Recently, UWDress.com, a popular ... women, has unveiled its new range of elegant ... in this new assortment. All the company's new and ... to 62 percent off. , This experienced company ... corset bridesmaid dresses, simple bridal gowns, backless party outfits, ...
(Date:8/27/2014)... All Canada Goose Parkas from CanadaGooseJackor.nu are ... to modern. With unique detailing such as buttons, leather trim ... step up in opulence. Recently, the company has unveiled its ... 2014. , True enough, the new assortment comes in ... to 28% off) on all these brand new items. By ...
(Date:8/27/2014)... Top 10 Best SEO Hosting, a well-known ... suppliers and announced iPage, Bluehost and GoDaddy are the most ... and Europe to buy useful hosting (including VPS and cloud ... iPage has been serving hosting small business websites ... grown into a leader in the hosting industry for its ...
(Date:8/27/2014)... August 27, 2014 New Jersey’s own ... The Ridgewood County Club during The Barclays – and ... each of the tournament’s four rounds, stepped his way ... Blue Cross Blue Shield of New Jersey (Horizon BCBNSNJ) ... a Wyckoff native playing before family and friends at ...
Breaking Medicine News(10 mins):Health News:National Resident Matching Program International (NRMPI) to Exhibit at the 2014 AMEE Conference 2Health News:Elegant Bridesmaid Dresses For 2014 Now Available At UWDress.com 2Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2Health News:Well-known SEO Hosts Review Site Top10BestSEOHosting.com Recommends iPage, Bluehost and GoDaddy To Webmasters 2Health News:Morgan Hoffmann, PGA TOUR Pro & Wyckoff Native, golfs and walks his way to top 10 finish at The Barclays while raising additional $7,500 for charity 2
... be at play, researchers note , , THURSDAY, May ... suffered fatal cardiac arrest were more likely to have ... survived heart attacks. , But the findings haven,t been ... directly cause any problems. Those who take the drugs ...
... Office of the Vice President of Research at ... its Collaborative Research Seed Grant Program (CRSGP) and ... programs help UTSA faculty establish new, innovative, collaborative ... of UTSA,s five strategic areas of excellence: health, ...
... theft and provides actionable advice to manage, report and ... Search America(R) , a part of Experian and a ... unveiled its Red Flags Rule system designed to help ... Discrepancy Rule from the Federal Trade Commission (FTC). This ...
... Provide Testing Tools to Students taking Board ExamsNEW ... Professional, a leading global provider of information resources ... USMLEasy ( http://www.usmleasy.com ) ... McGraw-Hill that offers institutional access. This innovative testing ...
... care improves level of overall functioning and mental ... suggests a recent Finnish study. , Jorvi Early ... University Central Hospital (HUCH), Jorvi Hospital, Finland, is ... adolescents at risk of developing first-episode psychosis. As ...
... Napa, Calif., (May 14, 2009) Dey, L.P., a ... data from two presentations highlighting the use of Perforomist ... format at the International Conference of the American Thoracic ... , In one analysis, use of Perforomist Inhalation ...
Cached Medicine News:Health News:Psychiatric Drugs Might Raise Cardiac Death Risk 2Health News:UTSA announces funding for new faculty research 2Health News:SearchAmerica(R) Unveils Next-Generation Red Flags Rule System for Health Care 2Health News:SearchAmerica(R) Unveils Next-Generation Red Flags Rule System for Health Care 3Health News:SearchAmerica(R) Unveils Next-Generation Red Flags Rule System for Health Care 4Health News:New Online Institutional Resource in Test Preparation Launched by McGraw-Hill Professional 2Health News:New Online Institutional Resource in Test Preparation Launched by McGraw-Hill Professional 3Health News:Early and network-oriented care may help adolescents at risk of developing psychosis 2Health News:Perforomist Inhalation Solution data to be presented at American Thoracic Society conference 2Health News:Perforomist Inhalation Solution data to be presented at American Thoracic Society conference 3
... for a way to help your patients ... disease? Based on the outcomes of ... (ECP) has improved the quality of their ... normal activities of daily living. , ,MedCath ...
... lab? Worried about the high costs, start-up ... of managing the ongoing business operations? As ... leaving you free to care for your patients., ... convenient diagnostic facility for you and your patients. ...
... currently maintains a large number of mobile, ... in its rental fleet. The labs are ... to several years. The Cath Lab Leasing ... while replacing or upgrading existing equipment, initiating ...
... laser combines excellent cutting, ablation and ... procedures. It is also extremely effective ... stones of all compositions, making it ... its laser light is transmitted through ...
Medicine Products: